Literature DB >> 4208506

Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.

P K Yu, J A Washington.   

Abstract

Kanamycin, BB-K8, and gentamicin were tested in parallel against 1,037 bacterial strains isolated from clinical material. The activity of BB-K8 at 20 mug/ml was comparable to that of gentamicin at 8 mug/ml against Pseudomonas aeruginosa and against Enterobacteriaceae, with the exception of gentamicin-resistant strains of Proteus rettgeri and Providencia stuartii, in which case the activities of BB-K8 and kanamycin were the same. BB-K8 exhibited little or no activity against streptococci. The activity of BB-K8 was affected by pH and inoculum size. A regression graph for inhibition data with a 10-mug disk of BB-K8 was developed, and synergistic activity of penicillin and BB-K8 against Streptococcus faecalis was tested.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4208506      PMCID: PMC444518          DOI: 10.1128/AAC.4.2.133

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  The mutual effects of antimicrobial compounds and metallic cations.

Authors:  E D WEINBERG
Journal:  Bacteriol Rev       Date:  1957-03

2.  Reversal of the antibacterial activity of polymyxin by divalent cations.

Authors:  B A NEWTON
Journal:  Nature       Date:  1953-07-25       Impact factor: 49.962

3.  BB-K 8, a new semisynthetic aminoglycoside antibiotic.

Authors:  H Kawaguchi; T Naito; S Nakagawa; K I Fujisawa
Journal:  J Antibiot (Tokyo)       Date:  1972-12       Impact factor: 2.649

4.  Ototoxicity studies with BB-K8, a new semisynthetic aminoglycoside antibiotic.

Authors:  J C Reiffenstein; S W Holmes; G H Hottendorf; M E Bierwagen
Journal:  J Antibiot (Tokyo)       Date:  1973-02       Impact factor: 2.649

5.  In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration.

Authors:  J A Washington; P E Hermans; W J Martin
Journal:  Mayo Clin Proc       Date:  1970-07       Impact factor: 7.616

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations.

Authors:  C J Wilkowske; R R Facklam; J A Washington; J E Geraci
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

8.  In vitro susceptibility of gram-negative bacilli to gentamicin.

Authors:  J A Washington; R E Ritts; W J Martin
Journal:  Mayo Clin Proc       Date:  1970-02       Impact factor: 7.616

9.  Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection.

Authors:  W H Traub; M E Craddock; E A Raymond; M Fox; C E McCall
Journal:  Appl Microbiol       Date:  1971-09

10.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

View more
  15 in total

1.  Penetration of amikacin into the aphakic eye.

Authors:  R T Kasbeer; G A Peyman; D R May; P I Homer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-08-04

2.  Pharmacological evaluation of amikacin in neonates.

Authors:  J B Howard; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

3.  Activity of three aminoglycosides and two penicillins against four species of gram-negative bacilli.

Authors:  R J Weinstein; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

4.  Ototoxicity of amikacin.

Authors:  R E Black; W K Lau; R J Weinstein; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

5.  Antibiotic susceptibilities of human isolates of Pasteurella multocida.

Authors:  D L Stevens; J W Higbee; T R Oberhofer; E D Everett
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

6.  In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.

Authors:  M T Kelly; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

7.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

8.  Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections.

Authors:  P M Sharp; C A Saenz; R R Martin
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

9.  In vitro activity of netilmicin, gentamicin, and amikacin.

Authors:  R J Kantor; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

10.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.